Durvalumab vs Furosemide

Durvalumab vs Furosemide: Overview

This comparison examines the pharmacological differences between Durvalumab and Furosemide.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Furosemide: Loop diuretic inhibiting Na-K-2Cl cotransporter.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Furosemide — 2 hours.

Chemical Properties

Molecular Formula: Furosemide — C12H11ClN2O5S.

Molecular Weight: Furosemide — 330.7440 g/mol.

Type: Durvalumab — Antibody; Furosemide — Small molecule.